|High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats|
SK Panchal, H Poudyal, A Iyer, R Nazer, A Alam, V Diwan, K Kauter, ...
Journal of cardiovascular pharmacology 57 (1), 51-64, 2011
|Inflammatory lipid mediators in adipocyte function and obesity|
A Iyer, DP Fairlie, JB Prins, BD Hammock, L Brown
Nature Reviews Endocrinology 6 (2), 71, 2010
|Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive rats|
A Iyer, A Fenning, J Lim, GT Le, RC Reid, MA Halili, DP Fairlie, L Brown
British journal of pharmacology 159 (7), 1408-1417, 2010
|Diet‐induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism|
J Lim, A Iyer, L Liu, JY Suen, RJ Lohman, V Seow, MK Yau, L Brown, ...
The FASEB Journal 27 (12), 4757-4767, 2013
|C5aR and C3aR antagonists each inhibit diet‐induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling|
J Lim, A Iyer, JY Suen, V Seow, RC Reid, L Brown, DP Fairlie
The FASEB Journal 27 (2), 822-831, 2013
|Lysine acetylation in obesity, diabetes and metabolic disease|
A Iyer, DP Fairlie, L Brown
Immunology and cell biology 90 (1), 39-46, 2012
|Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats|
V Chan, A Fenning, A Iyer, A Hoey, L Brown
Current Pharmaceutical Biotechnology 12 (3), 429-436, 2011
|The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress|
A Iyer, V Chan, L Brown
Current cardiology reviews 6 (4), 291-297, 2010
|Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells|
JYW Mak, W Xu, RC Reid, AJ Corbett, BS Meehan, H Wang, Z Chen, ...
Nature communications 8 (1), 1-13, 2017
|The cardiovascular nutrapharmacology of resveratrol: pharmacokinetics, molecular mechanisms and therapeutic potential|
P A Kroon, A Iyer, P Chunduri, V Chan, L Brown
Current Medicinal Chemistry 17 (23), 2442-2455, 2010
|Potential health benefits of Indian spices in the symptoms of the metabolic syndrome: a review|
A Iyer, S Panchal, H Poudyal, L Brown
|Evaluation of the chronic complications of diabetes in a high fructose diet in rats|
J Patel, A Iyer, L Brown
|Histone deacetylase 7 promotes Toll-like receptor 4-dependent proinflammatory gene expression in macrophages|
MR Shakespear, DM Hohenhaus, GM Kelly, NA Kamal, P Gupta, ...
Journal of Biological Chemistry 288 (35), 25362-25374, 2013
|Towards isozyme-selective HDAC inhibitors for interrogating disease|
P Gupta, R C Reid, A Iyer, M J Sweet, D P Fairlie
Current topics in medicinal chemistry 12 (14), 1479-1499, 2012
|Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a|
V Seow, J Lim, A Iyer, JY Suen, JK Ariffin, DM Hohenhaus, MJ Sweet, ...
The Journal of Immunology 191 (8), 4308-4316, 2013
|Histone deacetylases in monocyte/macrophage development, activation and metabolism: refining HDAC targets for inflammatory and infectious diseases|
K Das Gupta, MR Shakespear, A Iyer, DP Fairlie, MJ Sweet
Clinical & translational immunology 5 (1), e62, 2016
|Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats|
A Iyer, K Kauter, M Alam, SH Hwang, C Morisseau, BD Hammock, ...
Experimental diabetes research 2012, 2011
|An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats|
A Iyer, J Lim, H Poudyal, RC Reid, JY Suen, J Webster, JB Prins, ...
Diabetes 61 (9), 2320-2329, 2012
|Cardiovascular changes during maturation and ageing in male and female spontaneously hypertensive rats|
V Chan, A Fenning, SP Levick, D Loch, P Chunduri, A Iyer, YL Teo, ...
Journal of cardiovascular pharmacology 57 (4), 469-478, 2011
|Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats|
A Iyer, TM Woodruff, MCL Wu, C Stylianou, RC Reid, DP Fairlie, ...
Journal of cardiovascular pharmacology 58 (5), 479-486, 2011